These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Segal BH; Barnhart LA; Anderson VL; Walsh TJ; Malech HL; Holland SM Clin Infect Dis; 2005 Jun; 40(11):1684-8. PubMed ID: 15889369 [TBL] [Abstract][Full Text] [Related]
7. Invasive fungal infections in patients with chronic granulomatous disease. Henriet S; Verweij PE; Holland SM; Warris A Adv Exp Med Biol; 2013; 764():27-55. PubMed ID: 23654055 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy. Anaissie EJ Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bielorai B; Toren A; Wolach B; Mandel M; Golan H; Neumann Y; Kaplinisky C; Weintraub M; Keller N; Amariglio N; Paswell J; Rechavi G Bone Marrow Transplant; 2000 Nov; 26(9):1025-8. PubMed ID: 11100285 [TBL] [Abstract][Full Text] [Related]
10. Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in Greece. Athanasakis K; Petrakis I; Kyriopoulos J J Med Econ; 2013; 16(5):678-84. PubMed ID: 23448409 [TBL] [Abstract][Full Text] [Related]
11. Recent advances and challenges in the treatment of invasive fungal infections. Shao PL; Huang LM; Hsueh PR Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990 [TBL] [Abstract][Full Text] [Related]
12. Fungal infection and increased mortality in patients with chronic granulomatous disease. Bassiri-Jahromi S; Doostkam A J Mycol Med; 2012 Mar; 22(1):52-7. PubMed ID: 23177814 [TBL] [Abstract][Full Text] [Related]
13. [Long-term treatment of patients with itraconazole for the prevention of Aspergillus infections in patients with chronic granulomatous disease (CGD)]. Petropoulou T; Liese J; Tintelnot K; Gahr M; Belohradsky BH Mycoses; 1994; 37 Suppl 2():64-9. PubMed ID: 7609746 [TBL] [Abstract][Full Text] [Related]
14. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study. Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967 [TBL] [Abstract][Full Text] [Related]
19. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Dotis J; Roilides E Int J Infect Dis; 2004 Mar; 8(2):103-10. PubMed ID: 14732328 [TBL] [Abstract][Full Text] [Related]
20. Advances in antifungal therapy. Sable CA; Strohmaier KM; Chodakewitz JA Annu Rev Med; 2008; 59():361-79. PubMed ID: 17967129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]